EntryPoint Capital, LLC
- SEC CIK
- 0001992519
- Latest filing
- Aug 13, 2026
MIRM holding history
Mirum Pharmaceuticals, Inc. in every 13F filed by EntryPoint Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MIRM overviewAll 13F holders of MIRMFull Q2 2026 holdings
- Shares (Q2 2026)
- 5,150
- Value
- $602.9K
- % of portfolio
- 0.1%
- Quarters held
- 9
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 5,150 | $602.9K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 5,150 | $475.8K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 5,150 | $406.8K | 0.2% | −2,728−34.6% | Reduced | Holders |
| Q3 2025 | 7,878 | $577.5K | 0.2% | +612+8.4% | Added | Holders |
| Q2 2025 | 7,266 | $369.8K | 0.2% | −2,409−24.9% | Reduced | Holders |
| Q1 2025 | 9,675 | $435.9K | 0.2% | +9,675 | New | Holders |
| Q3 2024 | 0 | $0 | 0.0% | −9,758−100.0% | Sold out | Holders |
| Q2 2024 | 9,758 | $333.6K | 0.2% | +8,090+485.0% | Added | Holders |
| Q1 2024 | 1,668 | $41.9K | <0.1% | −99−5.6% | Reduced | Holders |
| Q4 2023 | 1,767 | $52.2K | 0.1% | – | No prior filing | Holders |